NDC 71894-110 - Zolgensma
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71894-110
- Package NDCs from labels
- 71894-110-01
- Manufacturer
- Novartis Innovative Technologies Inc.
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zolgensma - Novartis Innovative Technologies Inc. | Novartis Innovative Technologies Inc. | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| 70% Isopropyl Alcohol | ISOPROPYL ALCOHOL | 4 Visions | 57ac6fef-21de-e214-e063-6394a90a6c9e | 2026-07-28 | Warnings | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | 4 Visions LLC | 57acc1ff-2564-1e61-e063-6394a90a3c91 | 2026-07-28 | Warnings | ND2M416302 |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Pharma care IPA Wipes | ISOPROPYL ALCOHOL | Enviro Specialty Chemicals Inc | 26ce919a-1765-4b44-9114-24ea7383a987 | 2026-07-24 | Warnings | 797544 ND2M416302 |
| DOCTOR INKS IPA WIPES | ISOPROPYL ALCOHOL | Enviro Specialty Chemicals Inc | f65f0ec4-fa2c-487d-a8cc-41cbb8c140a4 | 2026-07-24 | Warnings | 797544 ND2M416302 |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Verifine Alcohol Swabs | ALCOHOL SWABS | Promisemed Hangzhou Meditech Co.,LTD. | 5738a502-c5ab-21b0-e063-6294a90a20a7 | 2026-07-22 | Warnings | 797544 ND2M416302 |
| KeepGoing Sting Relief Pad | BENZOCAINE AND ISOPROPYL ALCOHOL | J&A Digital Inc. | a630db1b-1674-4659-a60f-56994b0a1564 | 2026-07-22 | Warnings | ND2M416302 |
| KeepGoing Alcohol Prep Pad | ISOPROPYL ALCOHOL | J&A Digital Inc. | 5d1e776b-4027-4d05-b02f-8a2701d7bc7a | 2026-07-22 | Warnings | 797544 ND2M416302 |
| PROVEN MEDICAL TESTING Alcohol Prep Pads | ISOPROPYL ALCOHOL | Proven Medical Testing, LLC | 21e0f7ea-e73e-4461-ab2b-50d456e1d70d | 2026-07-22 | Warnings | 797544 ND2M416302 |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Biopure 70% Isopropyl Alcohol Wipe | ISOPROPYL ALCOHOL, WIPE | QUEST USA CORP | 3a7932c4-6f90-a008-e063-6294a90aa769 | 2026-07-19 | Warnings | ND2M416302 |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.